Gisele Rosada Dônola Furtado
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gisele Rosada Dônola Furtado has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Kledson Lopes Barbosa
Professor Alberto Antunes University Hospital
5 shared publications - Ricardo Cesar Gobbi de Oliveira
Inga University Center
3 shared publications - Andréa Lisboa Sisnando
Ingá University Center, Department of Dentistry, Uningá, Paraná 87035-510, Brazil
2 shared publications - Célia Marisa Rizzatti-Barbosa
Universidade Estadual de Campinas
2 shared publications - José Reinaldo Araújo Souza
Inga University Center
2 shared publications - José Ricardo de Albergaria-Barbosa
Universidade Estadual de Campinas
2 shared publications
Latest Publications
- Open Access
- 13 January 2023
- Published by Research, Society and Development in Research, Society and Development
- Vol. 12 (2)
In vitro evaluation of viscosity of facial hyaluronic acid fillers through shear tension analysis. Preliminary data
To analyze and describe the viscosity and the stress in relation to the shear rate of eleven facial fillers of four commercial HA brands with authorized use in Brazil through the flow sweep rheological analysis method. The rheological parameter of viscosity (η) was analyzed by rheometry tests through flow sweep. The behavior of shear stress showed that Rennova Fill Lido® and Lift Lido® have higher viscosity ratios (ƞ = 336 Pa.s and ƞ = 406 Pa.s, respectively). In contrast, Hialurox® brand fillers showed the lowest viscosity value (ƞ) (Hialurox Ultra Soft 8 mg/g® ƞ= 9 Pa.s, Fine 16 mg/g ƞ= 29 Pa.s, Fill 24 mg/g ƞ= 36 Pa.s, Lift 26 mg/g ƞ= 50 Pa.s). The flow sweep showed variations in the viscosity (ƞ) of the eleven HA dermal fillers. Rennova Fill Lido® and Lift Lido® have a lower degree of spreadability and are less susceptible to shear forces and yield strength, making them ideal candidates for the intended treatment.
- 13 January 2023
- Published by Research, Society and Development in Research, Society and Development
- Vol. 12 (2)
Open AccessIn vitro evaluation of viscosity of facial hyaluronic acid fillers through shear tension analysis. Preliminary data
To analyze and describe the viscosity and the stress in relation to the shear rate of eleven facial fillers of four commercial HA brands with authorized use in Brazil through the flow sweep rheological analysis method. The rheological parameter of viscosity (η) was analyzed by rheometry tests through flow sweep. The behavior of shear stress showed that Rennova Fill Lido® and Lift Lido® have higher viscosity ratios (ƞ = 336 Pa.s and ƞ = 406 Pa.s, respectively). In contrast, Hialurox® brand fillers showed the lowest viscosity value (ƞ) (Hialurox Ultra Soft 8 mg/g® ƞ= 9 Pa.s, Fine 16 mg/g ƞ= 29 Pa.s, Fill 24 mg/g ƞ= 36 Pa.s, Lift 26 mg/g ƞ= 50 Pa.s). The flow sweep showed variations in the viscosity (ƞ) of the eleven HA dermal fillers. Rennova Fill Lido® and Lift Lido® have a lower degree of spreadability and are less susceptible to shear forces and yield strength, making them ideal candidates for the intended treatment.
- Open Access
- 28 December 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 12 (1)
Rheological properties of hyaluronic acid-based fillers for facial cosmetic aesthetics
Hyaluronic acid-based dermal fillers are the most used materials in cosmiatry, and their clinical implications are linked to their viscoelastic properties. This study aimed to determine the rheological behavior of HA products used in Brazil by changing specific physicochemical characteristics under different test frequencies. Laboratory analyses of 0.9 mL of samples were performed in a TA-Instruments AR-1500ex Rheometer at 25 °C, at oscillation frequencies of 100, 10, 1, and 0.1 radians/second, considering the measurements of G′, G′′, and Tan δ. The value of G' increased as the oscillation frequencies were increased. In parallel, the changes in G" were the ones that varied the most for frequencies 0.1 and 1 radian/second. The maximum G' was observed with Hialurox Ultra Lift® 26 mg/g (793.45; 554.06; 423.44 Pa, 100, 10 and 1 rad/s, respectively). While the lowest G' values were obtained with Rennova Ultra Deep® (43.01; 19.75; 10.75 and 10.42 Pa at 100, 10, 1, 0.1 rad/sec, respectively). The changes that occurred in the investigated properties indicated that hyaluronic acid-based fillers vary when subjected to different conditions of shear rate, which should be considered in their clinical indication for choosing the most appropriate material according to the region to be treated.
- 28 December 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 12 (1)
Open AccessRheological properties of hyaluronic acid-based fillers for facial cosmetic aesthetics
Hyaluronic acid-based dermal fillers are the most used materials in cosmiatry, and their clinical implications are linked to their viscoelastic properties. This study aimed to determine the rheological behavior of HA products used in Brazil by changing specific physicochemical characteristics under different test frequencies. Laboratory analyses of 0.9 mL of samples were performed in a TA-Instruments AR-1500ex Rheometer at 25 °C, at oscillation frequencies of 100, 10, 1, and 0.1 radians/second, considering the measurements of G′, G′′, and Tan δ. The value of G' increased as the oscillation frequencies were increased. In parallel, the changes in G" were the ones that varied the most for frequencies 0.1 and 1 radian/second. The maximum G' was observed with Hialurox Ultra Lift® 26 mg/g (793.45; 554.06; 423.44 Pa, 100, 10 and 1 rad/s, respectively). While the lowest G' values were obtained with Rennova Ultra Deep® (43.01; 19.75; 10.75 and 10.42 Pa at 100, 10, 1, 0.1 rad/sec, respectively). The changes that occurred in the investigated properties indicated that hyaluronic acid-based fillers vary when subjected to different conditions of shear rate, which should be considered in their clinical indication for choosing the most appropriate material according to the region to be treated.
- Open Access
- 12 August 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (11)
First ultrasound report of temporal extension of bichat fat: correlation between anatomy and ultrasonography
The knowledge of facial anatomy and its correlation with ultrasonography has been gaining ground in the clinical practice of several professionals. Therefore, the knowledge of facial anatomical structures through dynamic ultrasonography images must be understood as a critical element for the clinical practice of guided esthetic facial procedures. In this pictorial essay focuses on discussing unprecedented anatomical details Temporal Extension of Bichat Fat correlating the anatomy with routine ultrasonography images. Knowledge of the US features of the temporal and buccal extensions of Bichat's fat will help narrow the differential diagnosis and guide clinical decision-making through spatial resolution and the ability to assess these structures using muscle contraction dynamically.
- 12 August 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (11)
Open AccessFirst ultrasound report of temporal extension of bichat fat: correlation between anatomy and ultrasonography
The knowledge of facial anatomy and its correlation with ultrasonography has been gaining ground in the clinical practice of several professionals. Therefore, the knowledge of facial anatomical structures through dynamic ultrasonography images must be understood as a critical element for the clinical practice of guided esthetic facial procedures. In this pictorial essay focuses on discussing unprecedented anatomical details Temporal Extension of Bichat Fat correlating the anatomy with routine ultrasonography images. Knowledge of the US features of the temporal and buccal extensions of Bichat's fat will help narrow the differential diagnosis and guide clinical decision-making through spatial resolution and the ability to assess these structures using muscle contraction dynamically.
- Open Access
- 12 August 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (11)
Can the exacerbated synthesis of inflammatory markers in COVID-19 impair the response to treatments in patients with coronavirus?
In addition to chronic diseases and empirical therapies against COVID-19, other factors are responsible for the high mortality rate associated with COVID-19. The objective of this study was to verify whether the exacerbated synthesis of inflammatory markers resulting from COVID-19 could compromise patients with coronavirus. The bibliographic research was performed in the Pubmed, LILACS, and SciELO databases between December 2020 and July 2021. For this study, the terms "COVID-19," "Biomarkers," "SARS-COV-2," and “Coronavirus 2019" are in advanced mode to gather the best evidence for the proposal of this manuscript. In the present construct, it is argued that COVID-19 increases the susceptibility of patients to a high stage of inflammation, increasing the virulence factors of the virus and its dissemination through the human body, where the synthesis of inflammatory factors plays a crucial role in the worsening of the cases. The virulence of the virus can be decreased by correcting the synthesis of these inflammatory markers, as it can prevent a less ineffective immune response and even increase the resistance of patients. Consequently, clinical trials in this direction should be carried out from the perspective of modulating responses at the molecular level, to find out how they work and how the underexpression of inflammatory cytokines may reduce the aggravation of patients with coronavirus.
- 12 August 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (11)
Open AccessCan the exacerbated synthesis of inflammatory markers in COVID-19 impair the response to treatments in patients with coronavirus?
In addition to chronic diseases and empirical therapies against COVID-19, other factors are responsible for the high mortality rate associated with COVID-19. The objective of this study was to verify whether the exacerbated synthesis of inflammatory markers resulting from COVID-19 could compromise patients with coronavirus. The bibliographic research was performed in the Pubmed, LILACS, and SciELO databases between December 2020 and July 2021. For this study, the terms "COVID-19," "Biomarkers," "SARS-COV-2," and “Coronavirus 2019" are in advanced mode to gather the best evidence for the proposal of this manuscript. In the present construct, it is argued that COVID-19 increases the susceptibility of patients to a high stage of inflammation, increasing the virulence factors of the virus and its dissemination through the human body, where the synthesis of inflammatory factors plays a crucial role in the worsening of the cases. The virulence of the virus can be decreased by correcting the synthesis of these inflammatory markers, as it can prevent a less ineffective immune response and even increase the resistance of patients. Consequently, clinical trials in this direction should be carried out from the perspective of modulating responses at the molecular level, to find out how they work and how the underexpression of inflammatory cytokines may reduce the aggravation of patients with coronavirus.
- Open Access
- 12 August 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (11)
New evidence of photobiomodulation and ozone therapy combined in the treatment of Bell's palsy
Bell's palsy is the most common cause of unilateral facial palsy reported in the literature. This condition consists of causing rapid onset and unilateral peripheral paresis/paraesthesia of the seventh cranial nerve. Despite being well documented, its etiology is still uncertain, imposing difficulty in immediate treatment. The combination of laser therapy and ozone therapy was proposed as a new treatment method for Bell's palsy, as it combines the efficacy and response of a therapy with the benefits of a minimally invasive approach. In the present study, we describe the first treatment protocol combining laser therapy and ozone therapy in Brazil, as well as details of the technique for the treatment of Bell's palsy. Case Report: A 59-year-old female with paralysis and paresthesia in the right hemiface, diagnosed for Bell's palsy, underwent a combined treatment of laser therapy and ozone therapy (VK OzonTherapy). After the fourth treatment session, a great clinical response was observed, and another session of the VK OzonTherapy protocol was performed. The patient evolved with significant improvement in the sequelae of right hemifacial paralysis, oro-ocular and eye closure, with rapid recovery of muscle tone and correction of asymmetries. Conclusions: This Report shows that the VK OzonTherapy protocol is an adjunct tool for clinical practice capable of improving the aesthetic-functional quality of life in patients with recent unilateral facial palsy.
- 12 August 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (11)
Open AccessNew evidence of photobiomodulation and ozone therapy combined in the treatment of Bell's palsy
Bell's palsy is the most common cause of unilateral facial palsy reported in the literature. This condition consists of causing rapid onset and unilateral peripheral paresis/paraesthesia of the seventh cranial nerve. Despite being well documented, its etiology is still uncertain, imposing difficulty in immediate treatment. The combination of laser therapy and ozone therapy was proposed as a new treatment method for Bell's palsy, as it combines the efficacy and response of a therapy with the benefits of a minimally invasive approach. In the present study, we describe the first treatment protocol combining laser therapy and ozone therapy in Brazil, as well as details of the technique for the treatment of Bell's palsy. Case Report: A 59-year-old female with paralysis and paresthesia in the right hemiface, diagnosed for Bell's palsy, underwent a combined treatment of laser therapy and ozone therapy (VK OzonTherapy). After the fourth treatment session, a great clinical response was observed, and another session of the VK OzonTherapy protocol was performed. The patient evolved with significant improvement in the sequelae of right hemifacial paralysis, oro-ocular and eye closure, with rapid recovery of muscle tone and correction of asymmetries. Conclusions: This Report shows that the VK OzonTherapy protocol is an adjunct tool for clinical practice capable of improving the aesthetic-functional quality of life in patients with recent unilateral facial palsy.
- Open Access
- 12 August 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (11)
Niacinamide for the treatment of melasma: an integrative review of randomized clinical trials
Introduction: Melasma is a very common and difficult to treat hypermelanosis because it usually responds poorly to therapies, negatively affecting the quality of life of patients. Objective: to know and analyze the scientific evidence related to the treatment of patients with facial melasma treated with niacinamide. Method: a literature review was performed based on a data search in BIREME, PubMed, SciELO and ScienceDirect. Articles indexed in these electronic journals were included in the time frame from 2011 to 2019. Results: Evidence analyzes revealed a major impact on the appearance of facial melasma after niacinamide treatment. Well, the studies (100%) concluded improvement of the spots with the treatment time, improving the appearance of the skin. Conclusion: Evidence shows that niacinamide has a lightening property in adult women with improvement of melanic hyperpigmentation caused by melasma. However, there is very little evidence published in the last decade using pure niacinamide for increased pigmentation in melasma. Introducción: El melasma es una hipermelanosis muy frecuente y de difícil tratamiento, ya que suele responder mal a las terapias, afectando negativamente la calidad de vida de los pacientes. Objetivo: conocer y analizar la evidencia científica relacionada con el tratamiento de pacientes con melasma facial tratados con niacinamida. Método: se realizó una revisión de la literatura a partir de una búsqueda de datos en BIREME, PubMed, SciELO y ScienceDirect. Los artículos indexados en estas revistas electrónicas se incluyeron en el período de 2011 a 2019. Resultados: los análisis de evidencia revelaron un impacto importante en la aparición del melasma facial después del tratamiento con niacinamida. Pues bien, los estudios (100%) concluyeron mejora de las manchas con el tiempo de tratamiento, mejorando el aspecto de la piel. Conclusiones: La evidencia muestra que la niacinamida tiene una propiedad aclarante en mujeres adultas con mejoría de la hiperpigmentación melánica causada por el melasma. Sin embargo, hay muy poca evidencia publicada en la última década sobre el uso de niacinamida pura para el aumento de la pigmentación en el melasma. Introdução: O melasma é uma hipermelanose bastante comum e de difícil tratamento porque geralmente responde mal as terapias, afetando negativamente a qualidade de vida dos pacientes. Objetivo: conhecer e analisar as evidências científicas relacionadas ao tratamento de pacientes com melasma facial tratados com niacinamida. Método: foi realizada uma revisão de literatura com base em uma busca de dados no BIREME, PubMed, SciELO e ScienceDirect. Os artigos indexados nesses periódicos eletrônicos foram incluídos no espaço temporal de 2011 até 2019. Resultados: As análises das evidências revelaram impacto importante na aparência do melasma facial após o tratamento com niacinamida. Pois, os estudos (100%) concluíram melhora das manchas com o tempo de tratamento, melhorando a aparência da pele. Conclusões: As evidências mostram que a niacinamida possui propriedade clareadora em mulheres adultas com melhora da hiperpigmentação melânica causada pelo melasma. No entando, há pouquíssimas evidências publicadas na última década com uso da niacinamida pura para pigmentação aumentada no melasma.
- 12 August 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (11)
Open AccessNiacinamide for the treatment of melasma: an integrative review of randomized clinical trials
Introduction: Melasma is a very common and difficult to treat hypermelanosis because it usually responds poorly to therapies, negatively affecting the quality of life of patients. Objective: to know and analyze the scientific evidence related to the treatment of patients with facial melasma treated with niacinamide. Method: a literature review was performed based on a data search in BIREME, PubMed, SciELO and ScienceDirect. Articles indexed in these electronic journals were included in the time frame from 2011 to 2019. Results: Evidence analyzes revealed a major impact on the appearance of facial melasma after niacinamide treatment. Well, the studies (100%) concluded improvement of the spots with the treatment time, improving the appearance of the skin. Conclusion: Evidence shows that niacinamide has a lightening property in adult women with improvement of melanic hyperpigmentation caused by melasma. However, there is very little evidence published in the last decade using pure niacinamide for increased pigmentation in melasma. Introducción: El melasma es una hipermelanosis muy frecuente y de difícil tratamiento, ya que suele responder mal a las terapias, afectando negativamente la calidad de vida de los pacientes. Objetivo: conocer y analizar la evidencia científica relacionada con el tratamiento de pacientes con melasma facial tratados con niacinamida. Método: se realizó una revisión de la literatura a partir de una búsqueda de datos en BIREME, PubMed, SciELO y ScienceDirect. Los artículos indexados en estas revistas electrónicas se incluyeron en el período de 2011 a 2019. Resultados: los análisis de evidencia revelaron un impacto importante en la aparición del melasma facial después del tratamiento con niacinamida. Pues bien, los estudios (100%) concluyeron mejora de las manchas con el tiempo de tratamiento, mejorando el aspecto de la piel. Conclusiones: La evidencia muestra que la niacinamida tiene una propiedad aclarante en mujeres adultas con mejoría de la hiperpigmentación melánica causada por el melasma. Sin embargo, hay muy poca evidencia publicada en la última década sobre el uso de niacinamida pura para el aumento de la pigmentación en el melasma. Introdução: O melasma é uma hipermelanose bastante comum e de difícil tratamento porque geralmente responde mal as terapias, afetando negativamente a qualidade de vida dos pacientes. Objetivo: conhecer e analisar as evidências científicas relacionadas ao tratamento de pacientes com melasma facial tratados com niacinamida. Método: foi realizada uma revisão de literatura com base em uma busca de dados no BIREME, PubMed, SciELO e ScienceDirect. Os artigos indexados nesses periódicos eletrônicos foram incluídos no espaço temporal de 2011 até 2019. Resultados: As análises das evidências revelaram impacto importante na aparência do melasma facial após o tratamento com niacinamida. Pois, os estudos (100%) concluíram melhora das manchas com o tempo de tratamento, melhorando a aparência da pele. Conclusões: As evidências mostram que a niacinamida possui propriedade clareadora em mulheres adultas com melhora da hiperpigmentação melânica causada pelo melasma. No entando, há pouquíssimas evidências publicadas na última década com uso da niacinamida pura para pigmentação aumentada no melasma.